Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-02-12

Clinical Trial Update: Flexible Insulin Therapy Untethered Insulin Regimen in Avidly Exercising Patients With Type 1 Diabetes: FIT Untethered [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on a flexible insulin therapy regimen for physically active individuals with Type 1 diabetes. The study is titled FIT Untethered a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)

Snippet

Sponsor: LMC Diabetes & Endocrinology Ltd. | Conditions: Type 1 Diabetes Mellitus | Phase 4 | Status: UNKNOWN